BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29368873)

  • 21. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
    Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A
    BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relevance of the clinical-pathological predictive factors in force in chromophobe renal cell cancer].
    Pardo P; Rodríguez-Faba O; Palou J; Algaba F; Breda A; Esquena S; Villavicencio H
    Actas Urol Esp; 2012 Oct; 36(9):527-31. PubMed ID: 22365081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of positive surgical margins on overall survival after partial nephrectomy-A matched comparison based on the National Cancer Database.
    Shum CF; Bahler CD; Sundaram CP
    Urol Oncol; 2018 Mar; 36(3):90.e15-90.e21. PubMed ID: 29223360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
    Blute ML; Amling CL; Bryant SC; Zincke H
    Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.
    Mouracade P; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Malkoc E; Kaouk JH
    World J Urol; 2017 Sep; 35(9):1425-1433. PubMed ID: 28197727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma.
    Suzuki K; Mizuno R; Mikami S; Tanaka N; Kanao K; Kikuchi E; Miyajima A; Nakagawa K; Oya M
    Jpn J Clin Oncol; 2012 Sep; 42(9):831-5. PubMed ID: 22811408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
    Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
    PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence risk groups after nephrectomy for renal cell carcinoma.
    Polanco Pujol L; Herranz Amo F; Caño Velasco J; Subirá Ríos D; Moralejo Gárate M; Hernández Cavieres J; Barbas Bernardos G; Bueno Chomón G; Rodríguez Fernández E; Hernández Fernández C
    Actas Urol Esp (Engl Ed); 2020 Mar; 44(2):111-118. PubMed ID: 31836313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of positive surgical margins on survival after partial nephrectomy in localized kidney cancer: analysis of the National Cancer Database.
    Ryan ST; Patel DN; Ghali F; Patel SH; Sarkar R; Yim K; Eldefrawy A; Cotta BH; Bradshaw AW; Meagher MF; Hamilton ZA; Murphy JD; Derweesh IH
    Minerva Urol Nephrol; 2021 Apr; 73(2):233-244. PubMed ID: 32748614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical margins after partial nephrectomy as prognostic factor for the risk of local recurrence in pT1 RCC: a systematic review and narrative synthesis.
    Henderickx MMEL; Baldew SV; Marconi L; van Dijk MD; van Etten-Jamaludin FS; Lagerveld BW; Bex A; Zondervan PJ
    World J Urol; 2022 Sep; 40(9):2169-2179. PubMed ID: 35503118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of renal function outcomes after nephron-sparing surgery and radical nephrectomy for nonsyndromic unilateral Wilms tumor.
    Cost NG; Sawicz-Birkowska K; Kajbafzadeh AM; Tourchi A; Parigi GB; Guillén G; DeFoor WR; Apoznanski W
    Urology; 2014 Jun; 83(6):1388-93. PubMed ID: 24768019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns and Predictors of Recurrence after Partial Nephrectomy for Kidney Tumors.
    Mouracade P; Kara O; Maurice MJ; Dagenais J; Malkoc E; Nelson RJ; Kaouk JH
    J Urol; 2017 Jun; 197(6):1403-1409. PubMed ID: 27993666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy.
    Minervini A; Serni S; Giubilei G; Lanzi F; Vittori G; Lapini A; Carini M
    Eur J Surg Oncol; 2009 May; 35(5):521-6. PubMed ID: 18640001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors for surgical margin status and recurrence in partial nephrectomy.
    Demirel HC; Çakmak S; Yavuzsan AH; Yeşildal C; Türk S; Dalkılınç A; Kireççi SL; Tokuç E; Horasanlı K
    Int J Clin Pract; 2020 Oct; 74(10):e13587. PubMed ID: 32558097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive margins after nephron-sparing surgery for renal cell carcinoma: long-term follow-up of patients on active surveillance.
    Lopez-Costea MA; Fumadó L; Lorente D; Riera L; Miranda EF
    BJU Int; 2010 Sep; 106(5):645-8. PubMed ID: 20067450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does a Positive Surgical Margin After Nephron Sparing Surgery Affect Oncological Outcome in Renal Cell Carcinoma? A Systematic Review and Meta-analysis.
    Hakam N; Abou Heidar N; Khabsa J; Hneiny L; Akl EA; Khauli R
    Urology; 2021 Oct; 156():e30-e39. PubMed ID: 34186133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical Approach Does Not Impact Margin Status After Partial Nephrectomy for Large Renal Masses.
    Ayangbesan A; Golombos DM; Golan R; O'Malley P; Lewicki P; Wu X; Scherr DS
    J Endourol; 2019 Jan; 33(1):50-60. PubMed ID: 29914269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.